Related references
Note: Only part of the references are listed.Sustained AT1R stimulation induces upregulation of growth factors in human cardiac fibroblasts via Gαq/TGF-β/ERK signaling that influences myocyte hypertrophy
Ratchanee Duangrat et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2022)
Primary Aldosteronism: State-of-the-Ar tReview
Anand Vaidya et al.
AMERICAN JOURNAL OF HYPERTENSION (2022)
Cardiac fibrosis
Nikolaos G. Frangogiannis
CARDIOVASCULAR RESEARCH (2021)
The Unrecognized Prevalence of Primary Aldosteronism A Cross-sectional Study
Jenifer M. Brown et al.
ANNALS OF INTERNAL MEDICINE (2020)
Impact of mineralocorticoid receptor blockade with direct renin inhibition in angiotensin II-dependent hypertensive mice
Atsushi Hashimoto et al.
HYPERTENSION RESEARCH (2020)
Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition
Jennifer Maning et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
p38 MAPK Pathway in the Heart: New Insights in Health and Disease
Rafael Romero-Becerra et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy
Simona Gallo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology
Alessandro Cannavo et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
NLRP3 Inflammasome Mediates Aldosterone-Induced Vascular Damage
Thiago Bruder-Nascimento et al.
CIRCULATION (2016)
Physiological and pathological cardiac hypertrophy
Ippei Shimizu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
TGF-β: the master regulator of fibrosis
Xiao-ming Meng et al.
NATURE REVIEWS NEPHROLOGY (2016)
Transforming growth factor beta1 and aldosterone
Kota Matsuki et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2015)
Telmisartan delays myocardial fibrosis in rats with hypertensive left ventricular hypertrophy by TGF-β1/Smad signal pathway
Yong Zhang et al.
HYPERTENSION RESEARCH (2014)
Cross-talk between mineralocorticoid receptor/angiotensin II type 1 receptor and mitogen-activated protein kinase pathways underlies aldosterone-induced atrial fibrotic responses in HL-1 cardiomyocytes
Chin-Feng Tsai et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Primary aldosteronism and impaired natriuresis in mice underexpressing TGFβ1
Masao Kakoki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Aldosterone/NaCl-induced renal and cardiac fibrosis is modulated by TGF-β responsiveness of T cells
Barbara Schreier et al.
HYPERTENSION RESEARCH (2011)
TGF-β stimulates biglycan synthesis via p38 and ERK phosphorylation of the linker region of Smad2
Micah L. Burch et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Effects of AT1-and β-adrenergic receptor antagonists on TGF-β1-induced fibrosis in transgenic mice
U. Seeland et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2009)
Aldosterone-induced TGF-beta(1) Expression is Regulated by Mitogen-Activated Protein Kinases and Activator Protein-1 in Mesangial Cells
Jeong-Sun Han et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2009)
Understanding the role of transforming growth factor-β signalling in the heart:: Overview of studies using genetic mouse models
Han Xiao et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2008)
MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets
Anthony J. Muslin
CLINICAL SCIENCE (2008)
Eplerenone attenuates myocardial fibrosis in the angiotensin II-induced hypertensive mouse: Involvement of tenascin-C induced by aldosterone-mediated inflammation
Tomohiro Nishioka et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
The role of TGF-β signaling in myocardial infarction and cardiac remodeling
Marcin Bujak et al.
CARDIOVASCULAR RESEARCH (2007)
Effect of dual blockade of renin-angiotensin system on TGFβ1 and left ventricular structure and function in hypertensive patients
R. Scaglione et al.
JOURNAL OF HUMAN HYPERTENSION (2007)
Examining potential therapies targeting myocardial fibrosis through the inhibition of transforming growth factor-beta 1
Razi Khan
CARDIOLOGY (2007)
CAMP inhibits transforming growth factor-β-stimulated collagen synthesis via inhibition of extracellular signal-regulated kinase 1/2 and Smad signaling in cardiac fibroblasts
Xiaoqiu Liu et al.
MOLECULAR PHARMACOLOGY (2006)
The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats
Osamu Tsukamoto et al.
CARDIOVASCULAR DRUGS AND THERAPY (2006)
Differences between cardiac and arterial fibrosis and stiffness in aldosterone-salt rats: Effect of eplerenone
Jobnny Nehme et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2006)
Cardioprotective mechanisms of spironolactone associated with the angiotensin-converting enzyme/epidermal growth factor receptor/extracellular signal-regulated kinases, NAD(P)H oxidase/lectin-like oxidized low-density lipoprotein receptor-1, and Rho-kinase pathways in aldosterone/salt-induced hypertensive rats
S Nakano et al.
HYPERTENSION RESEARCH (2005)
Excess aldosterone under normal salt diet induces cardiac hypertrophy and infiltration via oxidative stress
K Yoshida et al.
HYPERTENSION RESEARCH (2005)
Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy
N Tsybouleva et al.
CIRCULATION (2004)
TGF-β1 and angiotensin networking in cardiac remodeling
S Rosenkranz
CARDIOVASCULAR RESEARCH (2004)
Aldosterone directly stimulates cardiac myocyte hypertrophy
MP Okoshi et al.
JOURNAL OF CARDIAC FAILURE (2004)
Smad-dependent and Smad-independent pathways in TGF-β family signalling
R Derynck et al.
NATURE (2003)
Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure
WN Qin et al.
CIRCULATION RESEARCH (2003)
Alterations of β-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-β1
S Rosenkranz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
Transforming growth factor-β function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats
F Kuwahara et al.
CIRCULATION (2002)
Myocardial fibrosis in transforming growth factor-β1 (TGF-β1) transgenic mice is associated with inhibition of interstitial collagenase
U Seeland et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2002)
The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice
OF Bueno et al.
EMBO JOURNAL (2000)
Aldosterone and myocardial fibrosis in heart failure
CG Brilla
HERZ (2000)
TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice
D Zhang et al.
NATURE MEDICINE (2000)
Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth Factor-β1 transgene in the heart
H Nakajima et al.
CIRCULATION RESEARCH (2000)
Myocardial fibrosis in transforming growth factor β1 heterozygous mice
WW Brooks et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2000)
Share Paper
